Raymond James & Associates Vbi Vaccines Inc Transaction History

Raymond James & Associates

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 14, 2023	SELL	$0.29 - $0.64 $5,672 - $12,519	-19,561 Reduced 9.62%	183,818 $55,000
Q4 2022 Feb 08, 2023	SELL	$0.38 - $22.5 $33,751 - $2 Million	-88,820 Reduced 30.4%	203,379 $79,000
Q3 2022 Oct 25, 2022	SELL	$0.73 - $23.4 $101,688 - $3.26 Million	-139,299 Reduced 32.28%	292,199 $206,000
Q2 2022 Aug 12, 2022	SELL	$0.66 - $1.81 $161,711 - $443,482	-245,018 Reduced 36.22%	431,498 $349,000
Q1 2022 May 11, 2022	BUY	$1.27 - $2.47 $79,550 - $154,715	62,638 Added 10.2%	676,516 $1.12 Million
Q4 2021 Feb 08, 2022	SELL	$2.21 - $3.22 $417,840 - $608,798	-189,068 Reduced 23.55%	613,878 $1.44 Million
Q3 2021 Nov 02, 2021	SELL	$2.8 - $3.72 $11,510 - $15,292	-4,111 Reduced 0.51%	802,946 $2.5 Million
Q2 2021 Aug 11, 2021	BUY	$2.61 - $4.17 $68,888 - $110,062	26,394 Added 3.38%	807,057 $2.7 Million
Q1 2021 May 14, 2021	BUY	$2.91 - $4.32 $120,814 - $179,353	41,517 Added 5.62%	780,663 $2.43 Million
Q4 2020 Feb 12, 2021	BUY	$2.15 - $3.5 $4,790 - $7,798	2,228 Added 0.3%	739,146 $2.03 Million
Q3 2020 Nov 04, 2020	BUY	$2.77 - $6.17 $1.66 Million - $3.7 Million	599,650 Added 436.85%	736,918 $2.11 Million
Q2 2020 Jul 28, 2020	BUY	$0.87 - $3.13 $57,196 - $205,775	65,743 Added 91.92%	137,268 $426,000
Q1 2020 Apr 21, 2020	SELL	$0.73 - $1.91 $51,300 - $134,225	-70,275 Reduced 49.56%	71,525 $68,000
Q4 2019 Feb 12, 2020	BUY	$0.48 - $1.38 $68,064 - $195,683	141,800 New	141,800 $196,000

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

Stay updated on Raymond James & Associates with notifications on news.